New Kid ParagonDx Buys Gentris Diagnostics' Assets; Stratagene's Sorge Nabs Controlling Stake

Aug 29, 2007

NEW YORK (GenomeWeb News) — Newly formed company ParagonDx has acquired the assets of Gentris Diagnostics, a subsidiary of Gentris Corporation, and will focus on developing molecular diagnostic products for laboratories, the company said today.

The company, located in

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Main menu